Dementia

The UK biotech Bicycle Therapeutics announced a new partnership with the Dementia Discovery Fund (DDF) to use its novel platform to create new therapies for neurodegenerative diseases, that include dementia. The last decade has seen a run of late-stage drug failures in Alzheimer’s disease, and 2019 alone has seen two major programmes crash in the phase 3

Alzheimer’s Research UK is requesting help from the NHS and the pharmaceutical industry to join its new taskforce to ensure those diagnosed with dementia can access future treatments without needless delay. The charity stated it had created the new taskforce on the back of analysis showing that the UK health system “will need to think

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for patients with cognitive impairment due to dementia and schizophrenia. During the Phase 1b study, 28 healthy elderly subjects were given different doses of HTL9936, to test the effect of drug on measures of brain activity

The Medical Research Council (MRC) has announced the launch of the world’s largest study into dementia, involving more than two million people. The clinical study will be conducted through the Medical Research Council and industry partners. The UK Dementias Research Platform (UKDP) will investigate the causes of dementia across a range of different neurodegenerative conditions,